Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine in Advanced NSCLC
NCT01281124Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2011
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Jan 2011; status: completed.
02
Drugs
azacitidine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01281124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281124.